Sfoglia per AUTORE
RE A
Collezione AOU Novara

  

Items : 20

Carfilzomib, lenalidomide, dexamethasone (KRD) in BTKi relapsed or refractory mantle cell lymphoma: A phase II study from Fondazione Italiana Linfomi. in British journal of haematology / Br J Haematol. 2024 Jun 28. doi: 10.1111/bjh.19617.

2024
AOU Città della Salute di Torino
AOU Novara

Dodero A; Gaidano G; Fabbri A; Olivieri J; Arcaini L; Tani M; Zilioli VR; Visco C; Castiglione A; Re A; Lucchini E; Clerico M; Cavallo F; Zaja F;

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial. in Blood advances / Blood Adv. 2023 Jul 25;7(14):3764-3774. doi: 10.1182/bloodadvances.2022009504.

2023
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Cortelazzo S; Galimberti S; Palumbo GA; Puccini B; Ferreri AJM; Ballerini F; Lucchini E; Arcaini L; Moita F; Zilioli V; Balzarotti M; Boccomini C; Stefoni V; Cavallo F; Re A; Di Rocco A; Tavarozzi R; Ghislieri M; De Luca G; Zaccaria GM; Alessandria B; Genuardi E; Pironti M; Grimaldi D; Arrigoni E; Ferrero S; Di Paolo A; Ladetto M;

Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL. in Blood advances / Blood Adv. 2023 Aug 8;7(15):3916-3924. doi: 10.1182/bloodadvances.2023009744.

2023
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Tisi MC; Moia R; Visco C; Arcari A; Merli F; Stelitano C; Re A; Volpetti S; Zilioli VR; Pileri SA; Quaglia FM; Ferrante M; Bruna R; Di Rocco A; Chini C; Ghiggi C; Zambello R; Zanni M; Sciarra R; Celli M; Puccini B; Cencini E; Tani M; Botto B; Spina M; Ferrero S; Evangelista A; Patti C;

Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. in HemaSphere / Hemasphere. 2023 Apr 4;7(4):e837. doi: 10.1097/HS9.0000000000000837. eCollection 2023 Apr.

2023
AOU Città della Salute di Torino
AOU Novara

Ferretti VV; Ricardi U; Arcaini L; Ferrari S; Lazic T; Cristinelli C; Gotti M; Sciarra R; Pulsoni A; Merli F; Luminari S; Zerbi C; Trentin L; Pagani C; Dalceggio D; Pravato S; Visentin A; Alvarez I; Del Giudice I; D'Elia GM; Zoboli V; Annechini G; Tartaglia G; Bonfichi M; Filippi AR; Fabbri A; Liberati AM; Merli M; Nassi L; et alii...

Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project. in Hematological oncology / Hematol Oncol. 2022 Dec;40(5):953-961. doi: 10.1002/hon.3074. Epub 2022 Sep 15.

2022
AO Alessandria
AOU Novara

Nassi L; Stepanishyna Y; Federico M; Inghirami G; Re A; Rigacci L; Carson KR; Ferreri AJM; Luminari S; De Souza CA; Nagler A; Montoto S; Horwitz SM; Cabrera ME; Pileri SA; Zing NPC; Manni M; Miranda E; Fischer T; Chiattone C; Civallero M;

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial. in Blood advances / Blood Adv. 2021 Nov 9;5(21):4504-4514. doi: 10.1182/bloodadvances.2021005150.

2021
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara

Filippi AR; Freilone R; Ciccone G; Rota-Scalabrini D; Zilioli VR; Botto B; Abruzzese E; Zaja F; Tani M; Rigacci L; Santoro A; Simontacchi G; Grapulin L; Pulsoni A; Zanni M; Franzone P; Nassi L; Frezza GP; Nardella A; Re A; Buglione M; Pavone V; Gioia DM; Sacchetti GM; Gotti M; Evangelista A; Levis M; Ricardi U; Zinzani PL; et alii...

Correction: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study. in Leukemia / Leukemia. 2021 Mar;35(3):932. doi: 10.1038/s41375-020-01119-8.

2021
AOU Città della Salute di Torino
AOU Novara

Balzarotti M; Vitolo U; Krampera M; Arcaini L; Rule S; Petrucci L; Sica A; Ferrero S; De Celis MIA; Fabbri A; Polli V; Cox MC; Bozzoli V; Pennese E; Stefani PM; Gini G; Perrone T; Nassi L; McCulloch R; Chiappella A; Marin-Niebla A; Tecchio C; Sciarra R; Re A; Rusconi C; Hohaus S; Morello L; Quaglia FM; Zilioli VR; et alii...

Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study. in Leukemia / Leukemia. 2021 Mar;35(3):787-795. doi: 10.1038/s41375-020-01013-3. Epub 2020 Aug 11.

2021
AOU Città della Salute di Torino
AOU Novara

Balzarotti M; Vitolo U; Krampera M; Rule S; Petrucci L; Arcaini L; Sica A; Celis MIA; Ferrero S; Fabbri A; Polli V; Bozzoli V; Cox MC; Stefani PM; Pennese E; Perrone T; Nassi L; Gini G; McCulloch R; Marin-Niebla A; Chiappella A; Tecchio C; Sciarra R; Re A; Rusconi C; Hohaus S; Tisi MC; Morello L; Zilioli VR; et alii...

Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments. in Annals of hematology / Ann Hematol. 2021 Jan;100(1):303-304. doi: 10.1007/s00277-020-04344-4.

2021
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Zinzani P; Evangelista A; Levis A; Gioia D; Bonfichi M; Pavone V; Meli E; Nassi L; Tani M; Santoro A; Pulsoni A; Puccini B; Tucci A; Botto B; Molinari AL; Vitolo U; Pagani C; Sacchi S; Re A; Bari A; Marcheselli R;

MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Feb;8(2):e110-e121. doi: 10.1016/S2352-3026(20)30366-5.

2021
AOU Città della Salute di Torino
AOU Novara

Zambello R; Zucca E; Frezzato M; Osborne W; Liberati AM; Novak U; Cascavilla N; Davies A; Fox CP; Bernardi M; Gastaldi E; Cozens K; Fanni A; Singh V; Bromberg JEC; Re F; Patti C; Olivieri J; McKay P; Nassi L; Linton K; Botto B; Cellini C; Khwaja J; Cattaneo C; Re A; Cabras MG; Smith J; Ferreri AJM; et alii...

Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Apr 10;39(11):1214-1222. doi: 10.1200/JCO.20.02465. Epub 2021 Feb 12.

2021
AOU Città della Salute di Torino
AOU Novara

Spina M; Mammi C; Chimienti E; Marcheselli L; Tarantini G; Molinari A; Flenghi L; Kovalchuk S; Re F; Bottelli C; Tani M; Musuraca G; Di Rocco A; Nassi L; Lleshi A; Botto B; Hohaus S; Merli M; Sartori R; Gini G; Balzarotti M; Cox MC; Zanni M; Marino D; Zilioli VR; Pennese E; Ferrari A; Cencini E; Delamain MT; et alii...

Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi. in Frontiers in oncology / Front Oncol. 2021 Dec 6;11:789891. doi: 10.3389/fonc.2021.789891. eCollection 2021.

2021
AOU Novara

Re A; Merli M; Tisi MC; Lucchini E; Corradini P; Luminari S; Volpetti S; Tabanelli V; Casadei B; Tani M; Bruna R; Pileri S; Zinzani PL; Ballotta L; Varettoni M; Pesce EA; Zaja F;

The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments. in Annals of hematology / Ann Hematol. 2020 Feb;99(2):277-282. doi: 10.1007/s00277-019-03893-7. Epub 2019 Dec 23.

2020
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Re A; Pagani C; Tucci A; Botto B; Vitolo U; Molinari AL; Puccini B; Pulsoni A; Santoro A; Tani M; Nassi L; Meli E; Pavone V; Bonfichi M; Evangelista A; Gioia D; Levis A; Zinzani P; Bari A; Sacchi S; Marcheselli R;

Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study. in Annals of hematology / Ann Hematol. 2020 Feb;99(2):283-291. doi: 10.1007/s00277-019-03889-3. Epub 2019 Dec 23.

2020
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Zinzani PL; Gioia D; Kovalchuk S; Mannelli L; Stelitano C; Salvi F; Nassi L; Pagani C; Pulsoni A; Botto B; Spina M; Re A; Bonfichi M; Evangelista A; Santoro A; Dona M; Gotti M; Broccoli A; Rigacci L; Puccini B;

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death. in British journal of haematology / Br J Haematol. 2019 Jun;185(5):940-944. doi: 10.1111/bjh.15643. Epub 2018 Nov 8.

2019
AOU Città della Salute di Torino
AOU Novara

Loseto G; Pelosini M; Gentile M; Piazza F; Merli M; Marino D; Arcari A; Puccini B; Alvarez De Celis I; Ferrero S; Cox MC; Finolezzi E; Fabbri A; Molinari AL; Perrone T; Nassi L; Gini G; Morello L; Chiappella A; Tecchio C; Re A; Sciarra R; Hohaus S; Zilioli VR; Zoellner AK; Di Rocco A; Evangelista A; Tisi MC; Visco C; et alii...

Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (?70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL). in Leukemia & lymphoma / Leuk Lymphoma. 2019 Dec;60(12):2890-2898. doi: 10.1080/10428194.2019.1608529. Epub 2019 Jul 8.

2019
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara

Evangelista A; Peli A; Volpetti S; Pavone V; Pulsoni A; Arcari A; Tani M; Patti C; Nassi L; Musuraca G; Freilone R; Centurioni R; Re A; Zanni M; Stelitano C; Liberati AM; Massidda S; Tucci A; Luminari S; Salvi F; Spina M; Ladetto M; Merli F;

A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial. in Haematologica / Haematologica. 2018 May;103(5):849-856. doi: 10.3324/haematol.2017.184325. Epub 2018 Feb 22.

2018
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Ladetto M; Cortelazzo S; Gaidano G; Wiestner A; Piccin A; Liu D; Luminari S; Arcaini L; Rigacci L; Rusconi C; Vitolo U; Omedè P; Zamò A; Evangelista A; Carella AM; Re A; Dal Bo M; D'Agaro T; Ferrero S; Bomben R; Gattei V;

Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents. in PloS one / PLoS One. 2018 Dec 20;13(12):e0209216. doi: 10.1371/journal.pone.0209216. eCollection 2018.

2018
ASL Vercelli
AOU Novara

Minisini R; Bellomo G; Favretto S; Re A; Bianco S; Bonometti R; Burlone ME; Rigamonti C; Tran Minh M; Smirne C; Bellan M; Gualerzi A; Carnevale Schianca GP; Pirisi M;

Natural history and risk stratification of patients undergoing non-invasive ventilation in a non-ICU setting for severe COPD exacerbations. in Internal and emergency medicine / Intern Emerg Med. 2016 Oct;11(7):969-75. doi: 10.1007/s11739-016-1473-z. Epub 2016 Jun 2.

2016
ASL Vercelli
AOU Novara

Della Corte F; Campanini M; Balbo PE; Sola D; Bellan M; Colombo D; Re A; Sainaghi PP; Navalesi P; Pirisi M;

Natural history and risk stratification of patients undergoing non-invasive ventilation in a non-ICU setting for severe COPD exacerbations. in Internal and emergency medicine / Intern Emerg Med. 2016 Oct;11(7):1029-30. doi: 10.1007/s11739-016-1516-5. Epub 2016 Aug 2.

2016
ASL Vercelli
AOU Novara

Pirisi M; Navalesi P; Bellan M; Re A; Sainaghi PP;